Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Alpha Teknova, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 4.48M | 5.21M | +726.0K (+16.2%) |
| Value | $12.0M | $14.5M | +$2.51M (+20.9%) |
New holders (2)
Institutions that held Alpha Teknova, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Authentikos Wealth Advisory, LLC | 357 | $996 | 0.00% |
| Gotham Asset Management, LLC | 4,808 | – | – |
Sold out (5)
Institutions that held Alpha Teknova, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 59,700 | $159.0K |
| Y-Intercept (Hong Kong) Ltd | 44,757 | $119.5K |
| Old Mission Capital LLC | 15,484 | $41.3K |
| Rhumbline Advisers | 1,898 | $5.07K |
| New York State Common Retirement Fund | 57 | $152 |